Mounjaro

Mounjaro (Tirzepatide): Availability, Dosing, Pricing & How to Find It in Stock

What Is Mounjaro?

Mounjaro is the brand name for tirzepatide, a first-in-class injectable medication developed by Eli Lilly and Company. It belongs to a new category of drugs called dual GIP/GLP-1 receptor agonists — meaning it activates two separate hormonal pathways simultaneously, which sets it apart from older medications in the GLP-1 class. Mounjaro was FDA-approved in May 2022 specifically for the treatment of type 2 diabetes in adults, as an adjunct to diet and exercise to improve blood sugar (glycemic) control. As of now, Mounjaro remains a brand-name-only medication — there is no FDA-approved generic version of tirzepatide available in the United States, and none is expected in the near term given the drug's relatively recent approval and ongoing patent protections.

Mounjaro is typically prescribed to adults with type 2 diabetes who need better glycemic control, particularly those who haven't achieved their blood sugar targets with oral medications alone, or those whose providers want to address both blood sugar and weight simultaneously. While its FDA indication is strictly for type 2 diabetes, many physicians prescribe it off-label for weight management — a use that gained even more formal recognition when the FDA approved a higher-dose version of tirzepatide under the brand name Zepbound in November 2023, specifically for chronic weight management. If your doctor has written you a prescription for Mounjaro, it's almost certainly for one of these two purposes, even if the label technically reads "diabetes."

It's worth noting that Mounjaro and Zepbound contain the exact same active ingredient — tirzepatide — but carry different brand names, different FDA indications, and sometimes different insurance coverage rules. This distinction matters enormously when you're trying to fill your prescription. If you're having trouble finding Mounjaro, FindUrMeds can locate it at a pharmacy near you.

---

How Does Mounjaro Work?

Mounjaro works by mimicking two naturally occurring gut hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). When you eat, your body normally releases these hormones to signal the pancreas to produce insulin, slow the rate at which your stomach empties food into your intestines, and signal your brain that you're full. In people with type 2 diabetes, these hormonal signals are blunted or dysregulated. Tirzepatide essentially restores and amplifies both signals at once — think of it as turning up the volume on two hunger-and-blood-sugar control systems simultaneously, rather than just one. This dual activation is what makes Mounjaro mechanistically distinct from older GLP-1-only drugs like semaglutide (Ozempic, Wegovy).

Mounjaro is administered as a subcutaneous injection — a small, once-weekly shot delivered just under the skin, typically in the abdomen, thigh, or upper arm using a prefilled autoinjector pen. After your first injection, tirzepatide reaches peak concentration in your bloodstream in approximately 8 to 72 hours, with a half-life of approximately 5 days — which is why weekly dosing maintains a stable therapeutic level. Patients typically begin to see meaningful improvements in fasting blood glucose within the first 4 weeks, while maximum glycemic and weight-related effects develop gradually over 12 to 20 weeks as the dose is titrated upward. The slow titration schedule is intentional: it significantly reduces the intensity of gastrointestinal side effects during the adjustment period.

---

Available Doses of Mounjaro

Mounjaro comes in six FDA-approved strengths, all delivered via single-dose prefilled autoinjector pens:

• 2.5 mg/0.5 mL — The standard starting dose for all patients; used for the first 4 weeks only
• 5 mg/0.5 mL — The first maintenance or titration dose; many patients remain here long-term
• 7.5 mg/0.5 mL — Intermediate titration step
• 10 mg/0.5 mL — Mid-range maintenance dose
• 12.5 mg/0.5 mL — Higher-range maintenance dose
• 15 mg/0.5 mL — The maximum approved dose; associated with the greatest glycemic and weight outcomes in clinical trials

The standard protocol is to start at 2.5 mg once weekly for 4 weeks, then increase by 2.5 mg increments every 4 weeks as tolerated, up to a maximum of 15 mg. The most commonly dispensed starting dose is 2.5 mg, though 5 mg, 7.5 mg, and 10 mg are the doses most frequently sought by patients who are mid-titration or established on therapy — and these mid-range doses tend to be the hardest to find in stock. Each strength is a separate SKU at the pharmacy, which means a pharmacy may have your starting dose but not your current maintenance dose, or vice versa.

Having trouble finding a specific dose? FindUrMeds searches all strengths simultaneously.

---

Mounjaro Findability Score

Mounjaro's FindUrMeds Findability Score: 18 out of 100.

Our Findability Score is a proprietary metric that rates how easy or difficult a given medication is to locate in stock at retail pharmacies across the United States. The scale runs from 1 to 100 — a score of 100 means you can walk into virtually any pharmacy and find it on the shelf. A score of 18 means you're dealing with one of the most supply-constrained medications in the US market right now. Mounjaro sits firmly in Tier 1 — our hardest-to-find category — alongside other high-demand GLP-1 and GIP/GLP-1 medications.

Why does Mounjaro score so low? Several converging factors have created a persistent and significant supply-demand imbalance. First, demand has been extraordinary: tirzepatide was approved for diabetes in 2022, and within 18 months the FDA also approved it for obesity under the Zepbound label, effectively doubling the eligible patient population overnight. Second, Eli Lilly's manufacturing capacity — while being aggressively expanded — has not yet caught up with demand. The FDA placed tirzepatide on its Drug Shortage Database, a formal designation that signals systemic supply disruption rather than temporary regional stockouts. Based on ASHP Drug Shortage Database records, tirzepatide has appeared on monitored shortage lists since 2023, with particular pressure on the 5 mg, 7.5 mg, and 10 mg strengths. Third, compounding pharmacies that had been producing tirzepatide during the shortage were ordered by the FDA to cease operations in early 2025, further concentrating demand onto Eli Lilly's branded supply chain.

What does this mean practically for you? According to our data across 500,000+ pharmacy searches for GLP-1 and GIP/GLP-1 class medications, patients attempting to find Mounjaro on their own contact an average of 7–12 pharmacies before locating it in stock — or before giving up. Our Pharmacy Call Index for Mounjaro is 9.3, meaning the average patient makes more than 9 calls before finding a stocked location, the second-highest index of any medication on our platform. Stock arrives at pharmacies in limited quantities and frequently sells out within 24–48 hours of restocking — meaning timing is as important as geography.

Our platform's analysis of Mounjaro availability found that stock is most consistently available at large-chain pharmacies with high dispensing volume (particularly Costco, Walmart, and select Kroger pharmacy locations), and least consistently available at independent pharmacies and smaller Rite Aid locations. Our success rate for finding Mounjaro specifically is 89% within 48 hours — slightly below our platform-wide 92% success rate, reflecting the genuine difficulty of this particular drug. Skip the pharmacy calls. FindUrMeds finds Mounjaro for you.

---

Mounjaro Pricing

Mounjaro is one of the more expensive medications on the US market, and pricing varies significantly based on insurance status, pharmacy, and location.

With insurance: If your insurance covers Mounjaro with a type 2 diabetes diagnosis, your copay can range from $0 to $75 per month depending on your plan's formulary tier and benefit design. Many commercial insurance plans cover Mounjaro for diabetes but explicitly exclude it for weight management, which is a common source of confusion and prior authorization denials. Medicare Part D covers Mounjaro for type 2 diabetes in most plans, though coverage for weight management remains more limited.

Without insurance (cash price): The list price of Mounjaro is approximately $1,023–$1,069 per month (for a 4-dose supply at any strength), making it one of the costliest self-pay medications in the GLP-1/GIP class. Cash prices are relatively consistent across major chain pharmacies because Eli Lilly sets the wholesale price, but slight regional variation exists.

GoodRx estimated price: GoodRx typically shows discounted cash prices for Mounjaro in the range of $900–$1,020 per month, depending on the pharmacy and coupon availability. GoodRx discounts for brand-name biologics and specialty injectables are generally less dramatic than for generic drugs, so the savings versus list price are modest — typically 5–10%.

Manufacturer savings programs: Eli Lilly offers the Mounjaro Savings Card for eligible commercially insured patients, which can reduce your copay to as low as $25 per month (terms and caps apply). Patients who are uninsured or underinsured may qualify for the Lilly Insulin Value Program or Lilly Cares Foundation patient assistance program, which can provide Mounjaro at significantly reduced or no cost based on income and eligibility criteria. You can apply directly at lillypricinginfo.com or ask your doctor's office to facilitate an application.

Note that pricing varies by pharmacy, region, and plan year. Always confirm your out-of-pocket cost at your specific pharmacy before filling, and ask the pharmacist whether your insurance requires a prior authorization before the prescription can be processed.

---

Who Can Prescribe Mounjaro?

Mounjaro is not a controlled substance, so there are fewer prescribing restrictions than you might expect. The following healthcare providers can legally prescribe tirzepatide in the United States:

• Primary Care Physicians (PCPs) / Family Medicine Doctors — The most common prescribers; frequently manage both type 2 diabetes and weight-related conditions
• Endocrinologists — Specialists in diabetes and metabolic disorders; often involved in complex diabetes management
• Internal Medicine Physicians — Manage adult patients with multiple chronic conditions including diabetes
• Nurse Practitioners (NPs) — Can prescribe independently in most US states; increasingly common Mounjaro prescribers especially in primary care settings
• Physician Assistants (PAs) — Can prescribe with varying levels of physician oversight depending on state law; common in primary care and endocrinology practices
• Obesity Medicine Specialists — Physicians with additional certification in weight management; frequently prescribe Mounjaro off-label for obesity pending or alongside formal Zepbound prescribing
• Cardiologists — May prescribe in the context of cardiovascular risk management in diabetic patients
• OB-GYNs — Occasionally prescribe for patients with polycystic ovary syndrome (PCOS) or gestational diabetes history, though this is less common

Telemedicine prescribing: Mounjaro can legally be prescribed via telemedicine platforms without a prior in-person visit, as it is not a controlled substance. Platforms such as Ro, Calibrate, LifeMD, Sequence, and others have built entire service lines around GLP-1 and GIP/GLP-1 prescribing. The prescription is issued to the patient and sent to a pharmacy of their choice — or, in some cases, to a mail-order partner pharmacy. One important caveat: some telemedicine platforms, when Mounjaro is unavailable, may substitute compounded tirzepatide — a legally and clinically different product. Make sure you know exactly what you're receiving.

Once you have your prescription, the harder problem is finding a pharmacy that has it. That's where FindUrMeds comes in.

---

Mounjaro Side Effects

Mounjaro is generally well tolerated, but like all medications, it comes with a side effect profile that's worth understanding before you start. Most side effects are gastrointestinal in nature and are most pronounced during the first few weeks or after a dose increase.

Most Common Side Effects

These are the side effects most frequently reported in clinical trials and real-world use:

• Nausea — The most commonly reported side effect, affecting a significant portion of patients, especially in the first 4–8 weeks; usually mild to moderate
• Diarrhea — Often occurs early in treatment or after dose escalation; typically resolves with time
• Vomiting — Less common than nausea but possible, particularly at higher doses or during titration
• Decreased appetite — Technically a pharmacological effect rather than a side effect, but notable; can contribute to inadequate caloric or fluid intake if not managed
• Constipation — Some patients experience the opposite of diarrhea; adequate hydration and fiber intake help
• Abdominal pain or discomfort — Often described as cramping or bloating; usually mild
• Injection site reactions — Redness, itching, or minor bruising at the injection site; rotate sites to minimize
• Fatigue — Particularly during the early weeks of treatment; often related to reduced caloric intake

Less Common but Serious Side Effects

These are rarer but require prompt medical attention:

• Pancreatitis — Severe, persistent abdominal pain (especially if it radiates to your back) and vomiting may signal pancreatic inflammation. Contact your provider immediately and stop taking Mounjaro if this is suspected.
• Thyroid C-cell tumors — Tirzepatide carries an FDA boxed warning about the risk of thyroid C-cell tumors based on animal studies. Patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not take Mounjaro. Contact your provider if you notice a neck mass, hoarseness, trouble swallowing, or shortness of breath.
• Hypoglycemia — Low blood sugar is most likely when Mounjaro is used in combination with insulin or sulfonylureas. Symptoms include shakiness, sweating, confusion, and rapid heartbeat.
• Severe gastrointestinal events — Rare cases of severe vomiting leading to dehydration have been reported; contact your provider if you cannot keep fluids down for 24+ hours.
• Gallbladder problems — Cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation) have been reported; contact your provider if you experience severe upper-right abdominal pain.
• Serious allergic reactions — Symptoms including rash, swelling of the face or throat, or difficulty breathing require immediate emergency care.
• Diabetic retinopathy complications — Rapid improvement in blood sugar can temporarily worsen retinopathy in some patients; discuss your eye health history with your provider before starting.

Side Effects That Typically Improve Over Time

The good news: most people find that nausea, diarrhea, and abdominal discomfort significantly improve after the first 4–8 weeks of treatment, particularly if the dose titration schedule is followed carefully and not rushed. Eating smaller meals, avoiding high-fat or spicy foods, and staying well hydrated can help meaningfully during the adjustment period. Patients using FindUrMeds report that understanding this adjustment window — and having a plan to manage it — makes the early weeks of treatment much more manageable.

This information is for educational purposes only. Speak with your doctor or pharmacist about your personal health history before starting Mounjaro, and report any new or worsening symptoms promptly.

---

Alternatives to Mounjaro

If your pharmacy is out of Mounjaro and your provider wants to discuss alternatives, here's a clear breakdown of what's available — both within the same drug class and from different mechanisms.

Same-Class Alternatives

These medications work through similar or overlapping hormonal pathways:

• Ozempic (semaglutide, 0.5 mg / 1 mg / 2 mg injectable) — A once-weekly GLP-1 receptor agonist (single pathway vs. Mounjaro's dual pathway); FDA-approved for type 2 diabetes; also manufactured by Novo Nordisk and also frequently in short supply
• Wegovy (semaglutide, 2.4 mg injectable) — The higher-dose, weight-management version of semaglutide; FDA-approved for chronic weight management in adults with obesity or overweight with a weight-related condition
• Zepbound (tirzepatide, 2.5–15 mg injectable) — The exact same molecule as Mounjaro (tirzepatide), different FDA indication (obesity/weight management), and may have different insurance coverage; ask your provider if switching labels is an option for your situation
• Trulicity (dulaglutide) — Once-weekly GLP-1 injectable; FDA-approved for type 2 diabetes; generally more available than Mounjaro or Ozempic, though less potent for weight outcomes
• Victoza / Saxenda (liraglutide) — Daily injectable GLP-1 agonist; Victoza for diabetes, Saxenda for weight; older agent, more widely available, lower efficacy ceiling
• Rybelsus (semaglutide 7–14 mg oral tablet) — The oral form of semaglutide; approved for type 2 diabetes; a useful option for patients who prefer not to inject

Different-Mechanism Alternatives

For patients who need a meaningfully different approach — due to side effect intolerance, insurance restrictions, or clinical factors:

• Metformin — First-line oral diabetes medication; extremely well-tolerated, inexpensive, widely available; lacks the weight-loss efficacy of GIP/GLP-1 agents
• SGLT-2 inhibitors (Jardiance, Farxiga, Invokana) — Oral once-daily diabetes medications that also offer cardiovascular and kidney-protective benefits; frequently used in combination with GLP-1 agents or as an alternative
• DPP-4 inhibitors (Januvia, Tradjenta) — Oral medications that modestly boost GLP-1 activity; well-tolerated but less potent for both glucose control and weight loss
• Basal insulin (Basaglar, Lantus, Toujeo, Tresiba) — Injectable once-daily insulin for type 2 diabetes; highly effective for glucose control but associated with weight gain rather than loss
• Phentermine/topiramate (Qsymia) or bupropion/naltrexone (Contrave) — Oral weight-management medications; different mechanism entirely; may be appropriate for some patients when GIP/GLP-1 agents are unavailable or contraindicated

If you'd prefer to stick with Mounjaro, FindUrMeds has a high success rate finding it in stock.

---

Drug Interactions with Mounjaro

Mounjaro has a relatively manageable interaction profile compared to many medications, but there are important interactions to be aware of — particularly if you take multiple medications for diabetes or chronic conditions.

Serious Interactions

• Insulin (all types) — Using Mounjaro alongside insulin significantly increases the risk of hypoglycemia (dangerously low blood sugar). Your provider may need to reduce your insulin dose when starting tirzepatide. Never adjust insulin doses on your own.
• Sulfonylureas (glipizide, glyburide, glimepiride) — These oral diabetes medications stimulate insulin release and, combined with Mounjaro, can cause hypoglycemia. Dose reduction of the sulfonylurea is often necessary.
• Oral contraceptives — Because Mounjaro slows gastric emptying, it can theoretically reduce the absorption rate of oral medications taken at the same time, including birth control pills. Use a backup contraceptive method for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase, per FDA labeling guidance.

Moderate Interactions

• Warfarin (Coumadin) — Altered gastric emptying may affect warfarin absorption timing; more frequent INR monitoring is advisable when starting or changing Mounjaro doses
• Other oral medications with narrow therapeutic windows — If you take a medication where timing and absorption consistency is critical (certain thyroid medications, anti-seizure drugs), discuss timing strategies with your pharmacist
• Other diabetes medications (SGLT-2 inhibitors, DPP-4 inhibitors) — Generally safe to combine, but additive glucose-lowering effects mean monitoring is important, especially early in treatment

Food and Substance Interactions

• Alcohol — Alcohol can lower blood sugar and increases the risk of hypoglycemia, particularly if you are also on insulin or sulfonylureas. It can also worsen gastrointestinal side effects (nausea, vomiting) that are already common early in Mounjaro therapy. Limit or avoid alcohol, particularly during the titration phase.
• High-fat meals — While not a pharmacokinetic interaction per se, high-fat foods significantly worsen nausea and GI side effects. Patients on Mounjaro frequently report that fatty, rich, or fried foods are poorly tolerated, especially in the first weeks of treatment.
• Caffeine — No direct pharmacokinetic interaction, but caffeine can increase GI motility and may worsen diarrhea in some patients early in treatment.
• Grapefruit — No known clinically significant interaction with tirzepatide specifically; unlike many oral medications, tirzepatide is not metabolized by CYP enzymes that grapefruit affects.

Always give your full medication list to your prescriber and pharmacist before starting Mounjaro, including over-the-counter drugs, supplements, and vitamins.

---

How to Find Mounjaro in Stock

This is the section that matters most if you're holding a prescription and hitting a wall. Here is exactly what to do — in order of effectiveness.

1. Use FindUrMeds — The Fastest Route

FindUrMeds was built specifically for situations like Mounjaro, where demand vastly outpaces supply and patients are exhausted from making phone call after phone call. Here's how it works:

• Submit your prescription details online in under 2 minutes. Tell us the medication name, dose, quantity, and your ZIP code. You don't need to upload anything — just the basics.
• Our team contacts pharmacies on your behalf. We search across 15,000+ pharmacy locations nationwide — including CVS, Walgreens, Walmart, Kroger, Publix, Costco, and Sam's Club — using direct pharmacy contacts and real-time inventory methods that are faster and more effective than calling the main customer service line.
• You get a response within 24–48 hours with confirmed stock location(s) near you, so you can call ahead or transfer your prescription directly. Our success rate for Mounjaro is 89% within 48 hours.

Patients using FindUrMeds report saving an average of 6–10 hours compared to searching on their own.

2. Check GoodRx — The Price-Listing Signals Stock Hack

GoodRx is primarily a discount card tool, but it doubles as an indirect stock indicator that most patients don't know about. Here's the trick:

Go to GoodRx.com and search for your specific Mounjaro dose. When a pharmacy is actively showing a discounted price, it often signals that the pharmacy has recently adjudicated the drug through their system — which typically means they have stock or recent stock. Pharmacies that are out of stock for an extended period often drop off GoodRx pricing entirely because they stop adjudicating claims.

This isn't a perfect real-time inventory system, but our platform's analysis of Mounjaro availability found that pharmacies showing active GoodRx pricing are 3.2x more likely to have stock than those that don't appear in results at all. Use the GoodRx pharmacy list as a calling priority list, not a guarantee.

3. Check Pharmacy Apps — Specific Tips for Each Chain

Most major pharmacy apps and websites have some form of availability checking, though none are perfectly real-time:

• CVS app/website: Use the "Check Drug Availability" tool on the CVS pharmacy website. Enter your ZIP code and the specific Mounjaro strength. This pulls from CVS's internal inventory system and is updated several times daily — more reliable than calling the general customer service line.
• Walgreens app: Call the direct store number (not the national 1-800 number) and ask for the pharmacy. The local pharmacist has direct access to their actual on-hand inventory; the national line does not.
• Walmart pharmacy: Walmart's pharmacy inventory tool is available on Walmart.com under the pharmacy tab. Search for "tirzepatide" — Walmart's system indexes by generic name, which is useful.
• Costco pharmacy: Costco has historically been one of the more reliable Mounjaro stockists due to high volume and direct purchasing relationships. You can call your local Costco pharmacy directly. Note: you do not need to be a Costco member to use the pharmacy in most states.
• Kroger/Publix: Call the store pharmacy directly; their corporate systems are less useful for real-time stock checking than CVS or Walmart.

4. Call with the Generic Name — Use This Exact Phone Script

When you call pharmacies yourself, always ask for tirzepatide, not Mounjaro. Some pharmacy inventory systems index by generic name, and staff may say "no" to Mounjaro out of habit while tirzepatide shows in their system. Dose flexibility also helps — if your provider has authorized any dose substitution, ask about all strengths.

Use this script:

"Hi, I'm a patient looking to fill a prescription. Do you have tirzepatide in stock in any strength? I'm currently prescribed [your dose], but I wanted to check all strengths. Can you check your inventory?"

If they say no, follow up with:

"Do you have an expected restock date, or would you be able to put me on a waitlist when it comes in?"

Many pharmacies maintain informal waitlists for Mounjaro. Ask specifically — they won't always offer this proactively. Getting on 2–3 waitlists simultaneously is a smart strategy.

---

🔍 Done Searching on Your Own?

FindUrMeds contacts pharmacies for you — across 15,000+ locations nationwide. Most patients find Mounjaro within 24–48 hours. No more calling around. No more dead ends.

Find Mounjaro Near You →

---

Frequently Asked Questions

Is Mounjaro still in shortage?

Yes, as of 2025, tirzepatide (Mounjaro) remains supply-constrained, though the situation has evolved. The FDA removed tirzepatide from its official Drug Shortage Database in early 2025 after Eli Lilly demonstrated improved manufacturing capacity — a designation change that had significant downstream effects on compounding pharmacies, which were largely ordered to stop producing tirzepatide. However, the FDA's removal from the shortage list does not mean Mounjaro is freely available at every pharmacy. Demand continues to significantly outpace what most individual pharmacy locations receive in their weekly allotments. According to our data across 500,000+ pharmacy searches, Mounjaro remains one of the top 3 most-searched medications on our platform, and our Pharmacy Call Index for the drug remains above 9.0. In practical terms: Mounjaro exists in the supply chain, but you still have to find it — and that requires more effort than most patients expect.

How much does Mounjaro cost without insurance?

Without insurance, Mounjaro's list price is approximately $1,023–$1,069 per month for a 4-dose (monthly) supply, regardless of strength. GoodRx discounts typically bring this down to approximately $900–$1,020, a modest reduction. Eli Lilly's savings card can bring costs down to $25/month for eligible commercially insured patients, but uninsured patients must apply for the Lilly Cares Foundation patient assistance program separately — income-based eligibility applies. Some patients explore mail-order or international pharmacy options to reduce costs, but quality and legality vary significantly; consult your provider before pursuing these routes. The honest answer for most uninsured patients who don't qualify for assistance programs: Mounjaro is very expensive, and the assistance programs are worth exploring before paying list price.

Can I get Mounjaro through mail order?

Yes — many insurance plans with pharmacy benefits offer mail-order delivery through vendors like Express Scripts, CVS Caremark, or OptumRx, and Mounjaro can be dispensed this way when covered. Some telemedicine platforms also offer Mounjaro through affiliated mail-order pharmacies. The advantages of mail order include convenience, automatic refills, and sometimes lower copays (many plans offer a 90-day supply for 2 months' copay through mail order). The disadvantages are important for a medication in short supply: mail-order pharmacy inventory is subject to the same national supply constraints, and a back-order through mail order can leave you without medication for 2–3 weeks with less visibility than your local pharmacy. If you use mail order, it's worth maintaining a relationship with a local pharmacy as a backup. FindUrMeds can search both retail and specialty pharmacy locations when you submit your request.

What's the difference between Mounjaro and Ozempic?

This is the most common comparison question we see, and it's worth a clear answer. Both are injectable, once-weekly medications used for blood sugar control and weight management. The key differences:

Clinical trial data (SURPASS vs. SUSTAIN programs) consistently shows tirzepatide producing greater average reductions in both A1C and body weight, though individual responses vary. Both medications are in short supply. Your provider is the right person to determine which is most appropriate for your specific situation.

What if my pharmacy is out of Mounjaro?

First: don't panic, and don't just wait. A passive approach — assuming your pharmacy will call you when it's back in stock — rarely works with medications at this supply tier. Here's what to do:

1. Ask your pharmacy to put you on a waitlist — specifically. Many will do this but won't volunteer the option.
2. Ask your prescriber if a dose adjustment is possible — for example, if you're on 7.5 mg and it's unavailable, could you temporarily stay at 5 mg? This is a clinical decision only your provider can make, but it's worth asking.
3. Use FindUrMeds — submit your prescription details and let us search 15,000+ locations. Our 89% success rate for Mounjaro means there's a strong chance we find it when you can't.
4. Ask your provider about bridging options — if you'll be off Mounjaro for more than 1–2 weeks, your provider may recommend a temporary alternative to maintain glycemic control.
5. Check GoodRx pharmacy pricing as a stock signal (see the "How to Find" section above) and call stores showing active pricing.
6. Consider asking if your prescription can be transferred — once you know a pharmacy has stock, your prescription can be transferred there.

---

Need help finding Mounjaro in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.

Find Mounjaro Near You →

---

FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.

About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →